These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 35184686

  • 1. Ultrasound-targeted microbubble destruction-mediated miR-144-5p overexpression enhances the anti-tumor effect of paclitaxel on thyroid carcinoma by targeting STON2.
    Chen X, Zhang X, Qian Y, Xia E, Wang Y, Zhou Q.
    Cell Cycle; 2022 May; 21(10):1058-1076. PubMed ID: 35184686
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. miR-199b-5p-Stonin 2 axis regulates metastases and epithelial-to-mesenchymal transition of papillary thyroid carcinoma.
    Ren L, Xu Y, Qin G, Liu C, Yan Y, Zhang H.
    IUBMB Life; 2019 Jan; 71(1):28-40. PubMed ID: 30325582
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. UTMD-mediated delivery of miR-21-5p inhibitor suppresses the development of lung cancer.
    Zhou X, Liu H, Pang Y, Wang M, Liu S.
    Tissue Cell; 2022 Feb; 74():101719. PubMed ID: 34979378
    [Abstract] [Full Text] [Related]

  • 8. MiR-21-5p enhances the progression and paclitaxel resistance in drug-resistant breast cancer cell lines by targeting PDCD4.
    Tao L, Wu YQ, Zhang SP.
    Neoplasma; 2019 Sep; 66(5):746-755. PubMed ID: 31169019
    [Abstract] [Full Text] [Related]

  • 9. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p.
    Zang H, Li Y, Zhang X, Huang G.
    Thorac Cancer; 2020 Jul; 11(7):1891-1903. PubMed ID: 32445273
    [Abstract] [Full Text] [Related]

  • 10. miR-671-5p repressed progression of papillary thyroid carcinoma via TRIM14.
    Wang WJ, Yuan Y, Zhang D, Liu P, Liu F.
    Kaohsiung J Med Sci; 2021 Nov; 37(11):983-990. PubMed ID: 34292652
    [Abstract] [Full Text] [Related]

  • 11. miR-183-5p promotes proliferation, invasion, and glycolysis of thyroid carcinoma cells by targeting FOXO1.
    Han C, Mo K, Jiang L, Wang K, Teng L.
    Mol Cell Biochem; 2022 Apr; 477(4):1195-1206. PubMed ID: 35084673
    [Abstract] [Full Text] [Related]

  • 12. MiR-138-5p improves the chemosensitivity of MDA-MB-231 breast cancer cell line to paclitaxel.
    Rasoolnezhad M, Safaralizadeh R, Hosseinpour Feizi MA, Banan-Khojasteh SM, Roshani Asl E, Lotfinejad P, Baradaran B.
    Mol Biol Rep; 2023 Oct; 50(10):8407-8420. PubMed ID: 37620737
    [Abstract] [Full Text] [Related]

  • 13. LncRNA-HCG18 regulates the viability, apoptosis, migration, invasion and epithelial-mesenchymal transition of papillary thyroid cancer cells via regulating the miR-106a-5p/PPP2R2A axis.
    Zhu Y, Zhao J, Tan L, Lin S, Long M, Peng X.
    Pathol Res Pract; 2021 May; 221():153395. PubMed ID: 33798913
    [Abstract] [Full Text] [Related]

  • 14. Overexpression miR-211-5p hinders the proliferation, migration, and invasion of thyroid tumor cells by downregulating SOX11.
    Wang L, Shen YF, Shi ZM, Shang XJ, Jin DL, Xi F.
    J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28703321
    [Abstract] [Full Text] [Related]

  • 15. METTL3-mediated maturation of miR-589-5p promotes the malignant development of liver cancer.
    Liu J, Jiang K.
    J Cell Mol Med; 2022 May; 26(9):2505-2519. PubMed ID: 35348293
    [Abstract] [Full Text] [Related]

  • 16. MiR-192-5p inhibits proliferation, migration, and invasion in papillary thyroid carcinoma cells by regulation of SH3RF3.
    Fu S, Ma C, Tang X, Ma X, Jing G, Zhao N, Ran J.
    Biosci Rep; 2021 Sep 30; 41(9):. PubMed ID: 34486645
    [Abstract] [Full Text] [Related]

  • 17. Curcumol inhibits the growth of xenograft-tumors in mice and the biological activities of pancreatic cancer cells by regulating the miR-21-5p/SMAD7 axis.
    Fang S, Wang L, Luo C, Yi H, Wang X, Ning B.
    Cell Cycle; 2022 Jun 30; 21(12):1249-1266. PubMed ID: 35253605
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.